Haemo Pharma

Haemo Pharma is a specialty pharmaceutical company headquartered in Vienna, Austria, dedicated to the treatment of rare and chronic diseases. The company specializes in the fields of hematology, immunology, and intensive care, offering a portfolio that includes plasma-derived therapies and recombinant proteins. Haemo Pharma serves as a strategic partner for global biotechnology companies, managing the regulatory approval, marketing, and distribution of orphan drugs across Central and Eastern Europe. Their mission focuses on improving the quality of life for patients with conditions such as hemophilia, hereditary angioedema, and primary immunodeficiencies. By providing specialized medical expertise and a robust distribution network, the company ensures that innovative therapies reach patients in niche markets.